Health Canada's 72-Hour Rule for Foreign Recalls and Risks
Class II–IV licence holders must tell Health Canada within 72 hours when a foreign regulator recalls a device or flags a risk. How the rule works.
Read article →Practical guides on FDA, MHRA, Health Canada and EU MDR compliance, adverse-event and recall monitoring, PSUR reporting, and protecting your devices on the resale market.
Class II–IV licence holders must tell Health Canada within 72 hours when a foreign regulator recalls a device or flags a risk. How the rule works.
Read article →The GB post-market surveillance rules in force since June 2025: PMS plans, 15-day reporting, 3 working days to answer the MHRA, and field safety notices.
Read article →Device registration in swissdamed since 1 July 2026, the 31 December transition deadline, and Swissmedic's 2026 review of post-market surveillance files.
Read article →What the EUDAMED vigilance module covers, what will be public, when it is likely to become mandatory, and how to prepare for it.
Read article →Legacy devices still on the EU market must be registered in EUDAMED by 28 November 2026. Which devices count, the exceptions, and a checklist.
Read article →EUDAMED now holds every new device on the EU market. How to use its public data to find similar devices, check certificates and spot changes early.
Read article →What EUDAMED is, which modules are mandatory since May 2026, the November 2026 deadline for legacy devices, and how to check registration status quickly.
Read article →Where recalls and field safety notices are published in each market, why checking each site breaks down, and how to see them all in one device search.
Read article →Why reading MAUDE reports one by one tells you little, what a real adverse event signal looks like, and how to spot a rise in reports early.
Read article →The external data a PMS report or PSUR needs, why gathering it each cycle takes weeks, and how to produce the data annex on demand.
Read article →Why grey-market and counterfeit device listings keep turning up online, why searching by hand misses most of them, and how to go from watchlist to takedown.
Read article →Seven evaluation criteria, red flags to watch for, the questions that separate marketing from capability, and an evaluation checklist.
Read article →What the category covers, the four jobs it does, how it differs from a QMS, who uses it, and the one-question test for any tool.
Read article →Why unauthorized resale listings are a safety and liability risk, how devices end up on eBay, DotMed and LabX, and the watchlist-to-takedown workflow that stops them.
Read article →What the MHRA, Health Canada, Swissmedic, EUDAMED and EU Safety Gate each publish, why a problem often shows up in one country first, and how to bring them into one view.
Read article →FSNs vs MHRA alerts, where they're published on GOV.UK, Yellow Card reporting, the GB/Northern Ireland split, and how to monitor UK device safety information post-Brexit.
Read article →A developer's guide to api.fda.gov/device/event.json: search syntax, counting (the .exact rule), pagination, rate limits, API keys and the gotchas, with real working queries.
Read article →How to search the FDA MAUDE database (web search, openFDA API, bulk downloads), scope and run a repeatable monitoring workflow, and the limitations to respect.
Read article →Which EU MDR device classes need a PSUR vs a PMS Report, what goes in each, how often to update them, and who reviews them, with a side-by-side comparison.
Read article →What Articles 83–92 actually require: the PMS system, PMS plan, PSUR, serious-incident reporting timelines and trend reporting, explained in plain terms.
Read article →